The Future of Age-Related Macular Degeneration and Geographic Atrophy: How Clinical Trials Are Paving the Way

About this episode

This episode discusses the role of clinical trials in advancing care for age-related macular degeneration and geographic atrophy, featuring insights from Dr. Mathew MacCumber.

Clinical trials are essential to advancing care for age‑related macular degeneration (AMD) and geographic atrophy (GA). In this episode, Mathew MacCumber, MD, PhD, explains how clinical trials work, the potential benefits and challenges of participation, and key factors to consider when deciding whether a trial may be right for you. The discussion will also include a high-level overview of the GALLOP clinical trial for GA and what current research means for the future of vision health.

People in this episode

Guest: Mathew MacCumber, MD, PhD

Topics covered

• clinical trials
• age-related macular degeneration
• geographic atrophy
• vision health
• research advancements

Keywords

• clinical trials
• AMD
• GA
• vision health
• research
• participation
• benefits
• challenges

Mentioned in this episode

Organizations: BrightFocus Foundation

Books & works: GALLOP clinical trial

Places: age‑related macular degeneration, geographic atrophy

More episodes of Macular Chats

• Cell Therapy and Macular Degeneration: Exploring a New Treatment Frontier · April 29, 2026 · 34 min
• Understanding Macular Degeneration: A Listener Q&A Session · March 25, 2026 · 58 min
• Taking Charge of Wet AMD: Treatments & Tips · February 25, 2026 · 36 min
• Can Retinal Implants Restore Vision? · January 28, 2026 · 17 min
• Supporting the Supporters: Care Partners in Vision Loss · November 19, 2025 · 44 min